Oliver Luxxe Assets LLC Invests $1.47 Million in Ardent Health Partners, LLC (NYSE:ARDT)

Oliver Luxxe Assets LLC purchased a new stake in shares of Ardent Health Partners, LLC (NYSE:ARDT) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 85,754 shares of the company’s stock, valued at approximately $1,465,000.

Several other institutional investors also recently modified their holdings of the business. Wellington Management Group LLP bought a new position in Ardent Health Partners during the 3rd quarter valued at about $28,724,000. Point72 Asset Management L.P. purchased a new position in shares of Ardent Health Partners during the third quarter valued at approximately $27,428,000. Goldentree Asset Management LP bought a new position in Ardent Health Partners during the third quarter valued at approximately $22,897,000. Franklin Resources Inc. purchased a new stake in Ardent Health Partners in the third quarter worth approximately $15,839,000. Finally, Allspring Global Investments Holdings LLC bought a new stake in Ardent Health Partners in the 3rd quarter worth approximately $13,119,000.

Analyst Upgrades and Downgrades

Several brokerages recently commented on ARDT. Bank of America lowered Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their price objective for the stock from $22.00 to $19.00 in a report on Wednesday, November 6th. Leerink Partners raised their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a report on Tuesday, November 12th. KeyCorp began coverage on shares of Ardent Health Partners in a research note on Friday, October 11th. They set an “overweight” rating and a $24.00 price target on the stock. JPMorgan Chase & Co. restated a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Finally, Truist Financial cut their price target on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a report on Monday, January 6th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Ardent Health Partners has a consensus rating of “Buy” and a consensus price target of $21.55.

Ardent Health Partners Trading Up 5.0 %

Shares of NYSE ARDT opened at $15.27 on Friday. Ardent Health Partners, LLC has a 52-week low of $13.63 and a 52-week high of $20.72. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The company has a fifty day moving average of $16.11.

Ardent Health Partners (NYSE:ARDT) last issued its earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.10). The firm had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.46 billion. On average, research analysts forecast that Ardent Health Partners, LLC will post 1.22 earnings per share for the current year.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.